Certified Advisory Corp’s ARK Genomic Revolution ETF ARKG Stock Holding History

Certified Advisory Corp’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,419	Closed	-$209K	–	275
2022 Q4	$209K	Sell	7,419 -1,294	-15%	-$41.1K	0.04%	222
2022 Q3	$286K	Buy	8,713 +38	+0.4%	+$1.4K	0.07%	181
2022 Q2	$273K	Hold	8,675	–	–	0.06%	181
2022 Q1	$398K	Buy	8,675 +353	+4%	+$16.8K	0.08%	161
2021 Q4	$510K	Sell	8,322 -15	-0.2%	-$1.04K	0.11%	157
2021 Q3	$623K	Buy	8,337 +200	+2%	+$16.8K	0.15%	139
2021 Q2	$753K	Buy	8,137 +1,342	+20%	+$114K	0.19%	120
2021 Q1	$603K	Buy	+6,795	New	+$674K	0.16%	127
2020 Q2	$218K	Buy	4,187 +400	+11%	+$17.2K	0.07%	176
2020 Q1	$118K	Sell	3,787 -491	-11%	-$16.4K	0.05%	195
2019 Q4	$143K	Hold	4,278	–	–	0.05%	206
2019 Q3	$126K	Sell	4,278 -515	-11%	-$16.7K	0.04%	213
2019 Q2	$165K	Buy	4,793 +1,500	+46%	+$48.1K	0.06%	185
2019 Q1	$108K	Buy	3,293 +580	+21%	+$17.1K	0.05%	208
2018 Q4	$65K	Buy	2,713 +500	+23%	+$14.1K	0.03%	241
2018 Q3	$74K	Buy	+2,213	New	+$70K	0.03%	238

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Certified Advisory Corp's ARKG Position: Q1 2023 in Review

Certified Advisory Corp sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 7,419 shares — an estimated $209K sold.

Certified Advisory Corp first reported a position in ARKG in Q3 2018 and held it in 16 quarters. The position peaked at $753K in Q2 2021. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

Certified Advisory Corp reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
Certified Advisory Corp sold 7,419 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $209K.
Certified Advisory Corp first reported a position in ARK Genomic Revolution ETF in Q3 2018 and held it in 16 quarters.
Certified Advisory Corp's ARK Genomic Revolution ETF position peaked at $753K in Q2 2021.
295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Certified Advisory Corp's 13F filing for Q1 2023, filed 15 May 2023.